Does NIVOLUMAB Cause Aplastic anaemia? 52 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 52 reports of Aplastic anaemia have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.1% of all adverse event reports for NIVOLUMAB.
52
Reports of Aplastic anaemia with NIVOLUMAB
0.1%
of all NIVOLUMAB reports
21
Deaths
26
Hospitalizations
How Dangerous Is Aplastic anaemia From NIVOLUMAB?
Of the 52 reports, 21 (40.4%) resulted in death, 26 (50.0%) required hospitalization, and 7 (13.5%) were considered life-threatening.
Is Aplastic anaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIVOLUMAB. However, 52 reports have been filed with the FAERS database.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Aplastic anaemia?
ECULIZUMAB (345)
CYCLOPHOSPHAMIDE (332)
CYCLOSPORINE (331)
METHOTREXATE (281)
BUSULFAN (220)
FLUDARABINE (220)
ETOPOSIDE (186)
VINCRISTINE (173)
CYTARABINE (163)
ELTROMBOPAG OLAMINE (149)
Which NIVOLUMAB Alternatives Have Lower Aplastic anaemia Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE